Clinical Study of SARS-CoV-2 Variant mRNA Vaccine in Healthy Participants
Clinical trial NCT05599802 · UNKNOWN
Trial details
- NCT number
- NCT05599802
- Sponsor
- AIM Vaccine Co., Ltd.
- Status
- UNKNOWN
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2023-02-01
- Primary completion
- 2023-05-01
- Enrollment
- 144
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.